Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 May 22;19(5):1534.
doi: 10.3390/ijms19051534.

Skeletal Muscle MicroRNAs as Key Players in the Pathogenesis of Amyotrophic Lateral Sclerosis

Affiliations
Review

Skeletal Muscle MicroRNAs as Key Players in the Pathogenesis of Amyotrophic Lateral Sclerosis

Lorena Di Pietro et al. Int J Mol Sci. .

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder, for which, to date, no effective treatment to ameliorate the clinical manifestations is available. The long-standing view of ALS as affecting only motor neurons has been challenged by the finding that the skeletal muscle plays an active role in the disease pathogenesis and can be a valuable target for therapeutic strategies. In recent years, non-coding RNAs, including microRNAs, have emerged as important molecules that play key roles in several cellular mechanisms involved in the pathogenic mechanisms underlying various human conditions. In this review, we summarize how the expression of some microRNAs is dysregulated in the skeletal muscle of ALS mouse models and patients. Shedding light on the mechanisms underlying microRNAs dysregulation in the skeletal muscle could clarify some of the processes involved in the pathogenesis of ALS and especially identify new promising therapeutic targets in patients.

Keywords: amyotrophic lateral sclerosis; gene expression signature; microRNA; molecular biomarkers; molecularly targeted therapies; skeletal muscle.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
miR-206 signaling in slow and fast twitch muscles. miR-206 levels are higher in slow muscles than in fast ones and this basal expression makes the slow-twitch muscles more resistant to denervation. During the denervation process, typical of ALS disease, in fast-twitch muscles miR-206 levels increase to sustain re-innervation. Acting directly on microRNAs in the skeletal muscle could be a feasible therapeutic strategy aimed at making the muscle more resistant to denervation, increasing the responses that promote re-innervation (figure modified from https://smart.servier.com/). The green arrows link the different responses of slow- and fast-twitch muscles to the different miR-206 expression levels; the orange arrows show the signaling cascade in fast-twitch muscle following denervation; ↑: increased levels; ↓: decreased levels.

Similar articles

Cited by

References

    1. Writing Group Edaravone (MCI-186) ALS 19 Study Group. Safety and efficacy of edaravone in welldefined patients with amyotrophic lateral sclerosis: A randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2017;16:505–512. doi: 10.1016/j.expneurol.2003.10.004. - DOI - PubMed
    1. Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., Khan J., Polak M.A., Glass J.D. Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Exp. Neurol. 2004;185:232–240. doi: 10.1016/j.expneurol.2003.10.004. - DOI - PubMed
    1. Jokic N., Gonzalez de Aguilar J.L., Dimou L., Lin S., Fergani A., Ruegg M.A., Schwab M.E., Dupuis L., Loeffler J.P. The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model. EMBO Rep. 2006;7:1162–1167. doi: 10.1038/sj.embor.7400826. - DOI - PMC - PubMed
    1. Dupuis L., Gonzalez de Aguilar J.L., Echaniz-Laguna A., Eschbach J., Rene F., Oudart H., Halter B., Huze C., Schaeffer L., Bouillaud F., et al. Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons. PLoS ONE. 2009;4:e5390. doi: 10.1371/journal.pone.0005390. - DOI - PMC - PubMed
    1. Dadon-Nachum M., Melamed E., Offen D. The ‘dying-back’ phenomenon of motor neurons in ALS. J. Mol. Neurosci. 2011;43:470–477. doi: 10.1007/s12031-010-9467-1. - DOI - PubMed